404 related articles for article (PubMed ID: 33796213)
1. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.
Fernandez CJ; Agarwal M; Pottakkat B; Haroon NN; George AS; Pappachan JM
World J Gastrointest Surg; 2021 Mar; 13(3):231-255. PubMed ID: 33796213
[TBL] [Abstract][Full Text] [Related]
2. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
[TBL] [Abstract][Full Text] [Related]
3. Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms.
Takayanagi D; Cho H; Machida E; Kawamura A; Takashima A; Wada S; Tsunoda T; Kohno T; Shiraishi K
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267427
[TBL] [Abstract][Full Text] [Related]
4. Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
Reccia I; Pai M; Kumar J; Spalding D; Frilling A
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980746
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
6. Serum chromogranin A for the diagnosis of gastroenteropancreatic neuroendocrine neoplasms and its association with tumour expression.
Zhang C; Huang Y; Long J; Yao X; Wang J; Zang S; Qu W; Wang F
Oncol Lett; 2019 Feb; 17(2):1497-1504. PubMed ID: 30675205
[TBL] [Abstract][Full Text] [Related]
7. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.
Kidd M; Modlin I; Öberg K
Nat Rev Clin Oncol; 2016 Nov; 13(11):691-705. PubMed ID: 27273044
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract][Full Text] [Related]
9. Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms.
Que QY; Zhang LC; Bao JQ; Ling SB; Xu X
World J Gastrointest Surg; 2022 May; 14(5):397-408. PubMed ID: 35734618
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiles and Current Therapeutic Agents in Neuroendocrine Neoplasms.
Ohmoto A; Morizane C
Curr Drug Targets; 2020; 21(4):389-405. PubMed ID: 31633473
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).
Kaliszewski K; Ludwig M; Greniuk M; Mikuła A; Zagórski K; Rudnicki J
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454934
[TBL] [Abstract][Full Text] [Related]
12. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
13. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA
Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087
[TBL] [Abstract][Full Text] [Related]
14. Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.
Kidd M; Modlin IM; Bodei L; Drozdov I
Cell Mol Gastroenterol Hepatol; 2015 Mar; 1(2):131-153. PubMed ID: 28210673
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.
Sultana Q; Kar J; Verma A; Sanghvi S; Kaka N; Patel N; Sethi Y; Chopra H; Kamal MA; Greig NH
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568540
[TBL] [Abstract][Full Text] [Related]
16. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A;
BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616
[TBL] [Abstract][Full Text] [Related]
17. Medical Treatment of Gastrointestinal Neuroendocrine Neoplasms.
Tsoli M; Alexandraki K; Xanthopoulos C; Kassi E; Kaltsas G
Horm Metab Res; 2020 Aug; 52(8):614-620. PubMed ID: 32108932
[TBL] [Abstract][Full Text] [Related]
18. Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).
Grozinsky-Glasberg S; Lines KE; Avniel-Polak S; Bountra C; Thakker RV
Endocr Relat Cancer; 2020 Sep; 27(9):R345-R355. PubMed ID: 32590358
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms by nuclear medicine: Update and future perspective.
Ma X; Ding Y; Li W; Li Q; Yang H
Front Oncol; 2022; 12():1061065. PubMed ID: 36483036
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
